Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 Hours

Bayer

Status and phase: Completed; Phase 3

Conditions: Erectile Dysfunction

Treatments: Drug: Levitra (Vardenafil, BAY38-9456)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00668018

10678 (Registry Identifier)

Details and patient eligibility

About

Assess efficacy of vardenafil within 6 hours after intake

Enrollment: 887 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age: 18 years and older
• Males with erectile dysfunction
• Stable heterosexual relationship

Exclusion criteria

• Primary hypoactive sexual desire- History of myocardial infarction, stroke or life-threatening arrhythmia within the prior 6 months
• Nitrate use

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

887 participants in 1 patient group

Arm 1

Experimental group

Treatment:

Drug: Levitra (Vardenafil, BAY38-9456)